Alvotech (ALVO) EBT (2021 - 2026)

Alvotech (ALVO) has reported EBT for 6 consecutive years, with -$66.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 817.1% year-over-year to -$66.8 million; the trailing twelve-month figure through Jun 2026 stood at -$238.9 million (down 71.15% YoY), and the FY2025 full-year result was $136.3 million, up 162.67% from the prior year.
• EBT retreated to -$66.8 million in Q2 2026 per ALVO's latest filing, from $986000.0 in the prior quarter.
• Across five years, EBT topped out at $350.1 million in Q2 2022 and bottomed at -$651.0 million in Q1 2023.
• Historically, EBT has averaged -$152.9 million across 5 years, with a median of -$101.7 million in 2023.
• The widest YoY moves for EBT: up 147.22% in 2025, down 1014.56% in 2025.
• Over 5 years, EBT stood at -$551.6 million in 2022, then dropped by 18.02% to -$651.0 million in 2023, then soared by 66.58% to -$217.6 million in 2024, then soared by 147.22% to $102.7 million in 2025, then sank by 164.99% to -$66.8 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$66.8 million, $986000.0, and $102.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.